BDI Pharma's proprietary flu vaccine supply program SecuriFLU successful

BDI Pharma, Inc. (BDI), the fastest growing national wholesale distributor of biotech therapies, announced today the success of its proprietary supply program SecuriFLU. The program provides ordering solutions for customers who require quick, easy access to online ordering for flu vaccine. Customers may access brands from multiple manufacturers offering a full range of age indications. The site is designed to reduce the amount of time spent placing orders and provide a user-controlled ordering process. Customers are able to place orders for immediate delivery, pre-book for the following season and/or select from a customized list of delivery dates to fit their clinics' needs.

The SecuriFLU Program also serves as a clinical resource for consumers and healthcare providers alike. Data on influenza strains, along with CDC's guidelines and recommendations for influenza planning for the existing and upcoming seasons, are made available.

"We recognize not only the importance of making flu vaccine readily accessible, but also the greater value of offering supply and clinical solutions to our customers, especially with the heightened awareness this season due to concerns over the H1N1 (swine flu) pandemic," said Jennifer Jacobson, V.P., Corporate Programs for BDI. "The fact that we were able to ship 100% of our 2009-2010 pre-booked orders, as well as provide a limited number of additional doses to the community, effectively demonstrates that SecuriFLU reached its target audience in its inaugural year."